Subcortical white matter abnormalities related to drug resistance in Wilson disease

Neurology

Volumn 67, Issue 5, 2006, Pages 878-880

  Aikath, D ^a,b   Gupta, A ^a   Chattopadhyay, I ^a   Hashmi, M A ^a   Gangopadhyay, P K ^a   Das, S K ^a   Ray, K ^a,c  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b UNIVERSITY OF OREGON   (United States)

^c INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; PENICILLAMINE; WILSON DISEASE PROTEIN;

ANAMNESIS; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN DISEASE; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL FEATURE; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; ULTRASOUND; WHITE MATTER; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ANTIDOTES; BRAIN; CATION TRANSPORT PROTEINS; CHILD; CYSTEINE; DISEASE PROGRESSION; DRUG RESISTANCE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PENICILLAMINE;

EID: 33748709871     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000234130.27871.03     Document Type: Article

References (10)

1. Thomas GR, Roberts EA, Walshe JM, Cox DW. Haplotypes and mutations in Wilson disease. Am J Hum Genet 1995;56:1315-1319.
2. Walshe JM, Yealland M. Wilson's disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 1992;55:692-696.
3. King AD, Walshe JM, Kendall BE, et al. Cranial MR imaging in Wilson's disease. AJR Am J Roentgenol 1996;167:1579-1584.
4. Aisen AM, Martel W, Gabrielsen TO, et al. Wilson disease of the brain: MR imaging. Radiology 1985;157:137-141.
5. Starosta-Rubinstein S, Young AB, Kluin K, et al. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987;44:365-370.
6. Engelbrecht V, Schlaug G, Hefter H, Kahn T, Mädder U. Magnetic resonance imaging of the brain in Wilson's disease: T2 signal loss under therapy. J Comput Assist Tomogr 1995;19:635-638.
7. 123I-IBZM-SPECT. Eur Neurol 2000;43:187-188.
8. Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, Gitlin JD. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc Natl Acad Sci USA 2001;98:6848-6852.
9. Tao TY, Liu F, Klomp L, Wijmenga C, Gitlin JD. The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. J Biol Chem 2003;278:41593-41596.
10. Barnes N, Tsivkovskii R, Tsivkovskaia N, Lutsenko S. The copper-transporting ATPases, Menkes and Wilson disease proteins, have distinct roles in adult and developing cerebellum. J Biol Chem 2005;280:9640-9645.